Ian Ingram is a Deputy Managing Editor at MedPage Today. He specializes in medicine and healthcare, with a focus on topics such as the FDA, Coronavirus, CDC, data, and reviews, as well as alternative medicine and medical specialties. Ian's work has been featured in Knowledia, ExBulletin, and MedPage Today.
Preston is the artificial intelligence that powers the Intelligent Relations PR platform. Meet Preston
United States (National)
Not enough data
Ian Ingram's coverage is primarily focused on healthcare and pharmaceuticals, with a particular emphasis on clinical trial results, FDA approvals, and drug treatments for cancer and leukemia. He frequently cites data in his articles, indicating an interest in evidence-based reporting.
Pitching to Ian should involve providing access to newly released or exclusive clinical trial data, insights from key opinion leaders in the field of oncology or pharmaceuticals regarding recent developments in cancer treatment or FDA approval processes.
It's important to note that Ian does not have a specific geographic focus but covers international healthcare and pharmaceutical topics.
This information evolves through artificial intelligence and human feedback. Improve this profile .
FDA approves tapinarof cream 1% for adults and kids 2 years and up
Hall of Fame football player recently revealed his cholangiocarcinoma diagnosis
By: Ian Ingram
— Off-the-shelf product indicated for cases where autologous vein harvesting is not an option
— CFTR modulator carries boxed warning over risk of drug-induced liver injury and liver failure
Top stories in 2024 included major developments in abortion and
By: Ian Ingram
— News and commentary from the world of gastroenterology and hepatology
— Dazukibart targets specific molecular pathology of chronic systemic autoimmune disease
By: Ian Ingram
— News and commentary from the world of gastroenterology and hepatology
By: Ian Ingram
— News and commentary from the world of gastroenterology and hepatology
By: Ian Ingram
— News and commentary from the world of gastroenterology and hepatology
(833) 317-6278 
